You are here: Industry Insights > myocarditis

News List

Pharmacovigilance Risk Assessment Committee (PRAC) meeting highlights, Dec 2021 EuropeanPharmaceuticalReview
December 08, 2021
EMA’s drug safety committee (PRAC) confirmed the risks of of myocarditis and pericarditis with COVID-19 messenger RNA (mRNA) vaccines.
Risk for Myocarditis in Young Who Get Moderna Shots May Be Greater Than Thought drugs
August 23, 2021
The Moderna COVID-19 vaccine may be linked to a higher risk for myocarditis in younger adults than believed, emerging reports show.
Reported cases of myocarditis in younger men following COVID-19 vaccination are rare: Vaccination remains important, researchers stress firstwordpharma
June 30, 2021
Mayo Clinic researchers are taking a close look at rare cases of inflammation of the heart muscle, or myocarditis, in young men who developed symptoms shortly after receiving the second dose of the Moderna or Pfizer messenger RNA (mRNA) COVID-19 vaccines.
Investigation of reports of myocarditis in connection with COVID-19 mRNA vaccines firstwordpharma
June 07, 2021
Very rare reports received worldwide of myocarditis with a possible link to the use of mRNA vaccines against COVID-19 are currently under investigation.
Heart Issue Spotted in a Few Young COVID Vaccine Recipients drugs
May 25, 2021
A small number of teens and young adults have experienced heart inflammation after receiving mRNA COVID-19 vaccines produced by Pfizer and Moderna, the U.S. Centers for Disease Control and Prevention reports.
CDC Investigating Heart Problems in Teens, Young Adults After COVID-19 Vaccination drugs
May 25, 2021
Reports of myocarditis in a small number of teens and young adults who have received COVID-19 vaccines are being investigated by the U.S. Centers for Disease Control and Prevention.